This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Les Laboratoires Servier, Vernalis (R&D) Ltd. Active years: 2026.
Company Filing History:
1 out of 295 
1 out of 4 Years Active: 2026
Title: Emma Sanders - Innovator in Pharmaceutical Chemistry
Introduction
Emma Sanders is a talented inventor based in London, GB. She has made significant contributions to the field of pharmaceutical chemistry. Although she currently holds no granted patents, her work is focused on developing innovative medicinal products.
Latest Patent Applications
Emma's latest patent applications include:
1. 5-[7-(3,4-Dihydro-1H-isoquinoline-2-carbonyl)-1,2,3,4 tetrahydroisoquinolin-6-yl]-1H-pyrrole-3-carboxamide derivatives, which are useful in treating conditions requiring anti-apoptotic inhibitors.
2. Spirocyclohexane derivatives, which are also aimed at treating conditions requiring anti-apoptotic inhibitors.
Conclusion
Emma Sanders is an emerging inventor whose work in pharmaceutical chemistry shows great promise for future innovations. Her dedication to developing new medicinal products highlights her commitment to advancing healthcare solutions.